Anzeige
❌
Mehr »
Dienstag, 03.03.2026 - Börsentäglich über 12.000 News
1.000.000 $ staatliche Förderung - Startet hier Kanadas nächster Lithium-Champion?
Anzeige

Indizes
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Aktien
Kurs
%		News
24 h / 7 T		Aufrufe
7 Tage

Xetra-Orderbuch

Fonds
Kurs
%

Devisen
Kurs
%

Rohstoffe
Kurs
%

Themen
Kurs
%

Erweiterte Suche

WKN: A40C38 | ISIN: US36321W1053 | Ticker-Symbol: PY30
Siehe auch GALDERMA GROUP AG
Frankfurt
27.02.26 | 15:25
30,200 Euro
0,00 % 0,000
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
GALDERMA GROUP AG ADR Chart 1 Jahr
5-Tage-Chart
GALDERMA GROUP AG ADR 5-Tage-Chart

Aktuelle News zur GALDERMA GROUP AG ADR Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
GALDERMA GROUP AG ADR Aktie jetzt für 0€ handeln
FrGalderma's Nemluvio (nemolizumab) Demonstrates Long-Term Disease Control in Prurigo Nodularis up to Three Years304Business WireResults from an interim analysis of the OLYMPIA long-term extension (LTE) study show that Nemluvio maintained long-term disease control up to three years, with clinically meaningful improvements...
► Artikel lesen
MiGalderma erhält Zulassung für neue Restylane-Spritze in EU und Nordamerika5cash
MiGalderma Announces Triple Approval of New State-of-the-Art Restylane Syringe in the EU, the U.S., and Canada, Reaffirming the Company's Position at the Forefront of Injectable Aesthetics340Business WireRegulatory authorities in the European Union (EU), the United States (U.S.), and Canada have approved a new state-of-the-art Restylanesyringe for use with a range of Restylane NASHA lidocaine...
► Artikel lesen
Mi[GPTW] Galderma Korea GM named among Most Respected CEO in Korea3Korea Times
18.02.CFO-News: Mast-Jägermeister, Galderma, Oettinger9Finance Magazin
16.02.Galderma Group AG Names Luigi La Corte CFO, With Effect From May 13RTTNews
16.02.Galderma ernennt Luigi La Corte zum Finanzchef303MoneycabLausanne - Das Pharmaunternehmen Galderma hat Luigi La Corte zum neuen Finanzchef ernannt. Er tritt seinen Posten am 1. Mai 2026 an. La Corte bringe mehr als 30 Jahre Führungserfahrung im Finanzwesen...
► Artikel lesen
16.02.Galderma appoints Luigi La Corte as new CFO effective May 20266Investing.com
16.02.Galderma ernennt Luigi La Corte zum neuen Finanzchef ab Mai 20263cash
16.02.Wechsel an der Finanzspitze bei Galderma: Luigi La Corte wird neuer CFO6Investing.com Deutsch
16.02.Galderma Announces Appointment of New Chief Financial Officer254Business WireAd hoc announcement pursuant to Art. 53 LR Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced the appointment of Luigi La Corte as Chief Financial Officer...
► Artikel lesen
12.02.We Are All Sculptra: First-of-its-Kind Galderma Initiative to Demonstrate How Everyone Can Benefit from Sculptra's Regenerative Properties244Business WireGalderma unveils We Are All Sculptra, a global campaign capturing the clinical performance of Sculptraacross nine diverse patient profiles and journeys, over two years1 Backed by over 25...
► Artikel lesen
11.02.Galderma Expands Restylane Portfolio in Japan With Launch of OBT Hyaluronic Acid Injectables Restylane Defyne and Refyne474Business WireRestylane Refyne and Restylane Defyne are the first Optimal Balance Technology (OBT) hyaluronic acid injectables ever approved and launched in Japan, bringing advanced flexibility and natural...
► Artikel lesen
02.02.Galderma Announces U.S. FDA Acceptance of RelabotulinumtoxinA Biologics License Application Resubmission433Business WireThe United States (U.S.) Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) resubmission for RelabotulinumtoxinA for the temporary improvement of moderate-to-severe...
► Artikel lesen
30.01.Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity413Business WireResults from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of menopause on the skin, despite women experiencing around...
► Artikel lesen
29.01.Galderma Unveils 'Wake Up To Restylane', Underscoring Restylane as the Ideal Hyaluronic Acid Treatment for Always-On Natural Beauty434Business Wire'Wake Up To Restylane' is a global campaign designed to meet the rising demand for natural-looking always-on results, helping people wake up looking refreshed and rested, and reframes Restylane...
► Artikel lesen
22.01.Galderma und Ipsen beenden F&E-Partnerschaft für Neuromodulatoren nach Schiedsspruch20Investing.com Deutsch
22.01.IMCAS 2026: Galderma Showcases the Latest Scientific Advances Behind the Industry's Broadest Injectable Aesthetics Portfolio727Business WireAt IMCAS 2026, Galderma will present findings supporting Sculptra's regenerative properties and benefits on the body, including improving cellulite appearance, firmness, lift, projection, and...
► Artikel lesen
21.01.Ipsen Pharma: Arbitration tribunal upholds Ipsen's termination of R&D agreement with Galderma481GlobeNewswire (Europe)PARIS, FRANCE, 21 January 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced that the Arbitral Tribunal of the International Chamber of Commerce (ICC) has issued a final decision in favor of Ipsen,...
► Artikel lesen
21.01.Galderma Provides Update on Arbitration Case Regarding Neuromodulator Research and Development Partnership364Business WireGalderma (SIX:GALD), the pure-play dermatology category leader, today announced that an International Chamber of Commerce arbitral tribunal issued an award confirming the termination of a 2014 neuromodulator...
► Artikel lesen
1 2 3 4 5 Weiter >>
98 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1